SD and mean TTC under different weights. by Jianrong Cai (14245136)

“…Case study results show a significant decrease in SD as the CAV penetration rate increases, with a 58.38% reduction from 0% to 100%. …”

Parameter values. by Jianrong Cai (14245136)

“…Case study results show a significant decrease in SD as the CAV penetration rate increases, with a 58.38% reduction from 0% to 100%. …”

LPS induces ferroptosis of lung epithelial cells. by Yaping Yuan (2734228)

Statins resulted in smaller neuronal soma size. by Shuk C. Tsoi (21192243)

Statins induced flatter neuronal somas. by Shuk C. Tsoi (21192243)

Regression situation of each cross-section. by Puzhen An (21169189)

“…It also provides a better understanding of the combined impact of various construction parameters as the coarse particle content changes during the excavation process.…”

Statistical Table of Formation Loss Rate <i>V1.</i> by Puzhen An (21169189)

“…It also provides a better understanding of the combined impact of various construction parameters as the coarse particle content changes during the excavation process.…”

Fitting Results for Each Operating Condition. by Puzhen An (21169189)

“…It also provides a better understanding of the combined impact of various construction parameters as the coarse particle content changes during the excavation process.…”

Characterization of the impact of glucose/galactose on infection outcomes. by Tyron Chang (9922533)

Patient flowchart. by Anna D. Ware (19688153)

“…</p><p>Conclusions</p><p>Findings demonstrated that preexisting aspirin prescription prior to COVID-19 diagnosis was associated with significantly decreased risk of venous thromboembolism and pulmonary embolism but increased risk of acute arterial disease. …”

<i>Shroom3</i> is expressed throughout the mouse myocardium postnatally. by Jennifer L. Carleton (22208916)

Subjects:

<i>Shroom3</i> myocardial specific loss does not alter postnatal cardiac morphology. by Jennifer L. Carleton (22208916)

Subjects:

Developmental loss of <i>Shroom3</i> in the myocardium does not affect cardiomyocyte cross sectional area in adults. by Jennifer L. Carleton (22208916)

Subjects:

Myocardial <i>Shroom3</i> loss during development does not show abnormal semilunar valves. by Jennifer L. Carleton (22208916)

Subjects:

Embryos with compound <i>Shroom3</i>^<i>Gt/fl</i> alleles phenocopy <i>Shroom3</i>^<i>Gt/Gt</i> embryos. by Jennifer L. Carleton (22208916)

Subjects:

<i>Shroom3</i> is expressed in the mouse heart during cardiogenesis. by Jennifer L. Carleton (22208916)

Subjects:

Myocardial <i>Shroom3</i> loss during development does not show ventricular septal defects. by Jennifer L. Carleton (22208916)

Subjects:

Additional images of <i>Nkx2–5-Cre;Shroom3</i>^<i>fl/fl</i> neonate semilunar valve morphologies. by Jennifer L. Carleton (22208916)

Subjects:

Myocardial <i>Shroom3</i> loss during development does not alter ventricular wall thickness. by Jennifer L. Carleton (22208916)

Subjects:

Embryonic <i>Shroom3</i>^{<i>Gt</i>/<i>Gt</i>} hearts show ventricular septal defects. by Jennifer L. Carleton (22208916)

Subjects: